Copyright: ©Author(s) 2026.
World J Gastroenterol. Jan 14, 2027; 33(2): 125931
Published online Jan 14, 2027. doi: 10.3748/wjg.125931
Published online Jan 14, 2027. doi: 10.3748/wjg.125931
Table 1 Characteristics of included studies
| Reference | Grade of hemorrhoids | Treatment | Sample size | Recurrence | Effectiveness | Satisfaction | Further treatment | Pain | Bleeding | Urinary retention | Septic complications | Anorectal stenosis | Incontinence | Constipation |
| McKenzie et al[13], 2010 | II | RBL vs SH | 60 | Reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Sakr[14], 2010 | III/IV | MM vs LigaH | 84 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported |
| Nyström et al[15], 2010 | III/IV | MM vs SH | 180 | Not reported | Reported | Not reported | Not reported | Reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Abo-hashem et al[16], 2010 | III/IV | HarS vs BPC | 64 | Not reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Not reported | Reported | Not reported |
| Filingeri et al[17], 2010 | IV | FH vs RFC | 28 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Not reported |
| Sakr et al[18], 2010 | III/IV | SH vs LigaH | 68 | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported |
| Giordano et al[19], 2011 | II/III | SH vs HAL | 52 | Reported | Not reported | Reported | Reported | Reported | Reported | Reported | Not reported | Reported | Reported | Not reported |
| Zaher et al[20], 2011 | II/III/IV | SH vs RBL | 26 | Reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Not reported | Reported | Not reported |
| Franceschilli et al[21], 2011 | III/IV | MM vs LigaH | 210 | Reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported |
| Giamundo et al[22], 2011 | II/III | HAL vs RBL | 60 | Not reported | Reported | Reported | Not reported | Not reported | Reported | Reported | Not reported | Not reported | Reported | Not reported |
| Infantino et al[23], 2012 | III | SH vs HAL | 169 | Reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Reported | Not reported | Reported | Reported |
| Gupta et al[24], 2011 | III | SLM vs HAL | 48 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Not reported | Not reported | Not reported |
| Arslani et al[25], 2012 | III | SH vs LigaH | 98 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Not reported | Reported | Reported | Not reported |
| Filingeri et al[26], 2012 | II | RBL vs CHR | 90 | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Ammaturo et al[27], 2012 | III | MM vs SH | 79 | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Not reported | Reported | Not reported |
| Zampieri et al[28], 2012 | III/IV | HAL vs LigaH | 114 | Not reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Not reported | Reported | Not reported |
| Elmér et al[29], 2013 | II/III | MM vs HAL | 40 | Not reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Not reported | Reported | Reported | Not reported |
| Kim et al[30], 2013 | III | MM vs SH | 122 | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Not reported | Not reported | Reported | Not reported |
| Bulus et al[31], 2014 | III/IV | FH vs HarS | 151 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Reported | Not reported |
| Verre et al[32], 2013 | III/IV | HAL vs SH | 122 | Not reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Ahmad et al[33], 2013 | I/II | HAL vs IRC | 245 | Not reported | Reported | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Gagloo et al[34], 2013 | II/III | MM vs RBL | 100 | Not reported | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| De Nardi et al[35], 2014 | III | MM vs HAL | 50 | Reported | Not reported | Reported | Reported | Not reported | Reported | Not reported | Not reported | Reported | Reported | Not reported |
| Talha et al[36], 2017 | III/IV | MM vs HarS vs LigaH | 180 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Not reported | Reported | Not reported | Not reported |
| Denoya et al[37], 2014 | III/IV | FH vs HAL | 27 | Reported | Reported | Not reported | Reported | Reported | Reported | Not reported | Not reported | Reported | Reported | Not reported |
| Elshazly et al[38], 2015 | II/III | MM vs SLM | 200 | Reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Not reported | Not reported | Reported | Reported |
| Bilgin et al[39], 2015 | III/IV | SH vs HarS | 99 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Not reported |
| Wang et al[40], 2015 | III/IV | MM vs TST | 480 | Not reported | Reported | Reported | Not reported | Reported | Not reported | Reported | Not reported | Not reported | Reported | Reported |
| Lu et al[41], 2015 | III/IV | MM vs SH | 108 | Reported | Not reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Reported |
| Ripetti et al[42], 2015 | III/IV | MM vs SCH vs SH | 180 | Reported | Not reported | Not reported | Not reported | Reported | Reported | Reported | Not reported | Reported | Reported | Not reported |
| Aigner et al[43], 2016 | III | HAL vs SLM | 40 | Reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Zhai et al[44], 2016 | III | HAL vs SLM | 100 | Reported | Reported | Reported | Reported | Not reported | Reported | Reported | Not reported | Reported | Reported | Not reported |
| Brown et al[45], 2016 | II/III | HAL vs RBL | 372 | Reported | Reported | Not reported | Reported | Reported | Reported | Reported | Reported | Not reported | Not reported | Not reported |
| Leardi et al[46], 2016 | II/III | SH vs HAL | 100 | Reported | Not reported | Reported | Reported | Reported | Reported | Not reported | Not reported | Not reported | Reported | Not reported |
| Watson et al[47], 2016 | II/III/IV | MM vs SH | 774 | Reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported | Not reported | Reported |
| Lehur et al[48], 2016 | II/III | SH vs HAL | 393 | Reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported |
| Naderan et al[49], 2017 | II/III | MM vs LASER | 60 | Reported | Reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Not reported | Not reported | Not reported |
| Nikooiyan et al[50], 2016 | I/II/III/IV | FH vs DCV | 120 | Reported | Reported | Not reported | Reported | Reported | Reported | Reported | Reported | Not reported | Reported | Reported |
| Tsunoda et al[51], 2017 | III | HAL vs HarS | 44 | Not reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Not reported | Reported | Not reported | Not reported |
| Leung et al[52], 2017 | II/III | HAL vs TST | 80 | Reported | Not reported | Not reported | Reported | Not reported | Not reported | Reported | Not reported | Reported | Not reported | Not reported |
| Nikshoar et al[53], 2018 | III | FH vs IRC | 40 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Giarratano et al[54], 2018 | III/IV | SH vs HAL | 100 | Reported | Not reported | Reported | Reported | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| Venara et al[55], 2018 | II/III | SH vs HAL | 377 | Reported | Not reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported |
| Lisi et al[56], 2019 | III/IV | LigaH vs RFC | 50 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Not reported | Reported | Reported | Not reported |
| Carvajal López et al[57], 2019 | III/IV | MM vs HAL | 40 | Reported | Reported | Not reported | Reported | Reported | Reported | Reported | Not reported | Not reported | Not reported | Not reported |
| Trenti et al[58], 2019 | III/IV | LigaH vs HAL | 80 | Not reported | Not reported | Reported | Not reported | Not reported | Reported | Reported | Reported | Not reported | Not reported | Not reported |
| Genova et al[59], 2019 | III/IV | MM vs HAL | 89 | Reported | Not reported | Not reported | Reported | Not reported | Reported | Not reported | Reported | Reported | Not reported | Not reported |
| Poskus et al[60], 2020 | II/III | MM vs SLM vs LASER | 121 | Reported | Reported | Not reported | Reported | Not reported | Not reported | Not reported | Reported | Reported | Not reported | Not reported |
| Rørvik et al[61], 2020 | II/III/IV | MM vs HAL | 98 | Reported | Not reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported | Reported | Not reported |
| Abiodun et al[62], 2020 | II/III | IJS vs RBL | 60 | Reported | Reported | Reported | Reported | Reported | Reported | Not reported | Reported | Not reported | Not reported | Not reported |
| Jin et al[63], 2021 | III | RBL vs MM | 120 | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Not reported | Not reported | Not reported | Not reported |
| Zhai et al[64], 2022 | II/III/IV | SLM vs MM | 123 | Reported | Not reported | Reported | Reported | Not reported | Reported | Not reported | Not reported | Not reported | Reported | Not reported |
| Lee et al[65], 2021 | III/IV | HAL vs LigaH | 80 | Not reported | Reported | Reported | Reported | Reported | Reported | Reported | Not reported | Not reported | Not reported | Not reported |
| Huang et al[66], 2021 | III/IV | MM vs TST | 169 | Reported | Not reported | Reported | Not reported | Not reported | Reported | Reported | Not reported | Reported | Not reported | Not reported |
| Song et al[67], 2022 | III/IV | MPSH vs MM | 186 | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Reported | Not reported | Not reported |
| Salgueiro et al[68], 2022 | I/II/III | IJS vs RBL | 120 | Reported | Reported | Not reported | Reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Not reported |
| Trenti et al[69], 2023 | III/IV | HAL vs LigaH | 75 | Not reported | Not reported | Reported | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Reported | Not reported |
| Yang et al[70], 2022 | II/III/IV | SH vs MLPPH | 130 | Not reported | Reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Not reported | Not reported |
| Mert[71], 2023 | III/IV | LASER vs FH | 100 | Not reported | Reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Not reported | Reported | Not reported |
| Huang et al[72], 2023 | III/IV | TST vs SH | 306 | Reported | Reported | Not reported | Not reported | Not reported | Reported | Reported | Not reported | Reported | Not reported | Not reported |
| Cemil et al[73], 2024 | II/III | LASER vs MM | 85 | Not reported | Not reported | Not reported | Not reported | Not reported | Reported | Not reported | Not reported | Not reported | Reported | Not reported |
| Nada et al[74], 2024 | III/IV | HarS vs SH | 70 | Reported | Not reported | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Not reported |
| Jin et al[75], 2024 | II | LASER vs RBL | 70 | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Reported | Not reported | Reported | Not reported |
| Mustapha et al[76], 2025 | II/III/IV | LigaH vs MM | 52 | Not reported | Reported | Reported | Reported | Not reported | Not reported | Reported | Not reported | Not reported | Reported | Not reported |
| Huang et al[77], 2025 | III/IV | TST vs SH vs EPH | 141 | Not reported | Reported | Not reported | Not reported | Reported | Not reported | Reported | Not reported | Reported | Not reported | Not reported |
| Fernandez-Hurtado et al[78], 2025 | III | HAL vs MM | 50 | Reported | Reported | Not reported | Reported | Not reported | Not reported | Reported | Not reported | Reported | Reported | Not reported |
- Citation: Chen B, Xiong XR, Zhang ZG, Chen QQ. Comparison of efficacy and safety of different treatment modalities for hemorrhoids: A network meta-analysis. World J Gastroenterol 2027; 33(2): 125931
- URL: https://www.wjgnet.com/1007-9327/full/v33/i2/125931.htm
- DOI: https://dx.doi.org/10.3748/wjg.125931